{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:30:53Z","timestamp":1762522253516,"version":"3.44.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"am","delay-in-days":327,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006190","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17dm0107100h0002"],"award-info":[{"award-number":["17dm0107100h0002"]}],"id":[{"id":"10.13039\/100006190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP15K19758","JP16K10201","26430082"],"award-info":[{"award-number":["JP15K19758","JP16K10201","26430082"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.psychres.2019.01.052","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T11:16:46Z","timestamp":1547551006000},"page":"331-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Levels of lysophosphatidic acid in cerebrospinal fluid and plasma of patients with schizophrenia"],"prefix":"10.1016","volume":"273","author":[{"given":"Leo","family":"Gotoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misa","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3450-7283","authenticated-orcid":false,"given":"Daimei","family":"Sasayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takamasa","family":"Noda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kunugi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5649-2310","authenticated-orcid":false,"given":"Mitsuhiko","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1995","series-title":"Diagnostic and Statistical Manual of Mental disorders: DSM-IV: International Version With ICD-10 Codes.","key":"10.1016\/j.psychres.2019.01.052_bib0001"},{"key":"10.1016\/j.psychres.2019.01.052_bib0002","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1006\/bbrc.1997.6150","article-title":"Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid","volume":"231","author":"An","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.psychres.2019.01.052_bib0003","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3389\/fpsyt.2018.00209","article-title":"Blood-based lipidomics approach to evaluate biomarkers associated with response to olanzapine, risperidone, and quetiapine treatment in schizophrenia patients","volume":"9","author":"Aquino","year":"2018","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.052_bib0004","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/abio.2001.5063","article-title":"Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry","volume":"292","author":"Baker","year":"2001","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.psychres.2019.01.052_bib0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.humimm.2014.02.021","article-title":"Elevated serum levels of lysophosphatidic acid in patients with multiple sclerosis","volume":"75","author":"Balood","year":"2014","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.psychres.2019.01.052_bib0006","doi-asserted-by":"crossref","first-page":"e85348","DOI":"10.1371\/journal.pone.0085348","article-title":"1-Oleoyl lysophosphatidic acid: a new mediator of emotional behavior in rats","volume":"9","author":"Castilla-Ortega","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.psychres.2019.01.052_bib0007","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.cellsig.2010.03.010","article-title":"Subtype-specific role of phospholipase C-beta in bradykinin and LPA signaling through differential binding of different PDZ scaffold proteins","volume":"22","author":"Choi","year":"2010","journal-title":"Cell Signal"},{"key":"10.1016\/j.psychres.2019.01.052_bib0008","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1741-7015-11-126","article-title":"Toward the future of psychiatric diagnosis: the seven pillars of RDoC","volume":"11","author":"Cuthbert","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.psychres.2019.01.052_bib0009","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/pmic.201300520","article-title":"In-depth protein profiling of the postsynaptic density from mouse hippocampus using data-independent acquisition proteomics","volume":"14","author":"Distler","year":"2014","journal-title":"Proteomics"},{"key":"10.1016\/j.psychres.2019.01.052_bib0010","series-title":"Lysophospholipid Receptors: Signaling and Biochemistry","first-page":"451","article-title":"Role of Lysophosphatidic Acid (LPA) in behavioral processes: implications for psychiatric disorders.","author":"Estivill-Torr\u00fas.","year":"2013"},{"key":"10.1016\/j.psychres.2019.01.052_bib0011","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/B978-0-12-394307-1.00005-9","article-title":"Biological effects of lysophosphatidic acid in the nervous system","volume":"296","author":"Frisca","year":"2012","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.psychres.2019.01.052_bib0012","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.mcn.2003.09.001","article-title":"LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric disease","volume":"24","author":"Harrison","year":"2003","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.psychres.2019.01.052_bib0013","doi-asserted-by":"crossref","first-page":"11412","DOI":"10.1038\/srep11412","article-title":"Increased cerebrospinal fluid fibrinogen in major depressive disorder","volume":"5","author":"Hattori","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.psychres.2019.01.052_bib0014","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1083\/jcb.135.4.1071","article-title":"Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex","volume":"135","author":"Hecht","year":"1996","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.psychres.2019.01.052_bib0015","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1258\/acb.2008.007242","article-title":"Measurement of plasma lysophosphatidic acid concentration in healthy subjects: strong correlation with lysophospholipase D activity","volume":"45","author":"Hosogaya","year":"2008","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.psychres.2019.01.052_bib0016","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1440-1819.1998.00425.x","article-title":"Interrater reliability of the Japanese version of the Positive and Negative Syndrome Scale and the appraisal of its training effect","volume":"52","author":"Igarashi","year":"1998","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2019.01.052_bib0017","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/pcn.12275","article-title":"Psychotropic dose equivalence in Japan","volume":"69","author":"Inada","year":"2015","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2019.01.052_bib0018","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/01616412.2018.1446256","article-title":"Elevated lysophosphatidic acid levels in the serum and cerebrospinal fluid in patients with multiple sclerosis: therapeutic response and clinical implication","volume":"40","author":"Jiang","year":"2018","journal-title":"Neurol. Res."},{"key":"10.1016\/j.psychres.2019.01.052_bib0019","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull."},{"key":"10.1016\/j.psychres.2019.01.052_bib0020","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12944-017-0536-0","article-title":"Lysophosphatidic acid plasma concentrations in healthy subjects: circadian rhythm and associations with demographic, anthropometric and biochemical parameters","volume":"16","author":"Michalczyk","year":"2017","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.psychres.2019.01.052_bib0021","doi-asserted-by":"crossref","first-page":"e541","DOI":"10.1038\/tp.2015.33","article-title":"LPA signaling initiates schizophrenia-like brain and behavioral changes in a mouse model of prenatal brain hemorrhage","volume":"7","author":"Mirendil","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.052_bib0022","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nature13241","article-title":"Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid","volume":"509","author":"Nguyen","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.psychres.2019.01.052_bib0023","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1440-1819.2005.01408.x","article-title":"Reliability and validity of Japanese version of the Mini-International Neuropsychiatric Interview","volume":"59","author":"Otsubo","year":"2005","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2019.01.052_bib0024","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11064-005-2611-6","article-title":"Neurochemical changes in LPA1 receptor deficient mice: a putative model of schizophrenia","volume":"30","author":"Roberts","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.psychres.2019.01.052_bib0025","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"20","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.052_bib0026","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/s41380-018-0053-1","article-title":"Synaptic phospholipids as a new target for cortical hyperexcitability and E\/I balance in psychiatric disorders","volume":"23","author":"Thalman","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2019.01.052_bib0027","doi-asserted-by":"crossref","first-page":"25","DOI":"10.15252\/emmm.201505677","article-title":"Molecular cause and functional impact of altered synaptic lipid signaling due to a prg-1 gene SNP","volume":"8","author":"Vogt","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.psychres.2019.01.052_bib0028","unstructured":"Yamada, H., Masui, K., Kikuimoto, K., 1991. The Japanese version of The Positive and Negative Syndrome Scale (PANSS) rating manual. Seiwa Shoten, Tokyo."},{"key":"10.1016\/j.psychres.2019.01.052_bib0029","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00702-014-1289-9","article-title":"Lysophosphatidic acid induces anxiety-like behavior via its receptors in mice","volume":"122","author":"Yamada","year":"2015","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"4","key":"10.1016\/j.psychres.2019.01.052_bib0030","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/MBC.0000000000000034","article-title":"Patients with risk factors have higher plasma levels of lysophosphatidic acid: a promising surrogate marker for blood platelet activation","volume":"25","author":"Yao","year":"2014","journal-title":"Blood Coagul. Fibrinolysis"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178118312708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178118312708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:32:19Z","timestamp":1759037539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178118312708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":30,"alternative-id":["S0165178118312708"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2019.01.052","relation":{},"ISSN":["0165-1781"],"issn-type":[{"type":"print","value":"0165-1781"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levels of lysophosphatidic acid in cerebrospinal fluid and plasma of patients with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2019.01.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}